Predictive and prognostic value of serum AFP level and its dynamic changes in advanced gastric cancer patients with elevated serum AFP

Table 2 Comparison of objective response rates to different chemotherapy regimens n (%)

Regimen	Platinum-based doublet regimen(n = 58)	Taxane-based doublet regimen(n = 17)	Triplet regimen(n =11)	P value
Overall population				0.201
PR	31 (53.4)	5 (29.4)	6 (54.5)
SD + PD	27 (46.6)	12 (76.4)	5 (45.5)
AFP ≥ 160 ng/mL				0.067
PR	10 (32.3)	0 (0.0)	4 (57.1)
SD + PD	21 (67.7)	7 (100.0)	3 (42.9)
AFP < 160 ng/mL				0.193
PR	21 (77.8)	5 (50.0)	2 (50.0)
SD + PD	6 (22.2)	5 (50.0)	2 (50.0)

PR: Partial response; SD: Stable disease; PD: Progressive disease.